BINIMETINIB

BINIMETINIB was reported 7953 times

BINIMETINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SEROUS RETINOPATHY 59 0.5619
1 BACTERIAL URETHRITIS 2 0.5000
2 SEROUS RETINAL DETACHMENT 359 0.4284
3 DETACHMENT OF MACULAR RETINAL PIGMENT EPITHELIUM 4 0.0769
4 KERATOSIS FOLLICULAR 5 0.0641
5 MACULAR DETACHMENT 13 0.0537
6 AUTOIMMUNE ANAEMIA 2 0.0364
7 BRAF V600E MUTATION POSITIVE 2 0.0328
8 VOGT-KOYANAGI-HARADA DISEASE 7 0.0318
9 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 24 0.0270
10 INTRACRANIAL TUMOUR HAEMORRHAGE 10 0.0258
11 OCULAR TOXICITY 27 0.0245
12 ACNE CONGLOBATA 2 0.0244
13 TRANSIENT ACANTHOLYTIC DERMATOSIS 7 0.0238
14 CHLOROPSIA 3 0.0234
15 COLOUR BLINDNESS ACQUIRED 8 0.0220
16 CENTRAL SEROUS CHORIORETINOPATHY 15 0.0220
17 SUBRETINAL FLUID 22 0.0201
18 EYE SYMPTOM 7 0.0196
19 METASTATIC MALIGNANT MELANOMA 45 0.0196
20 THYROGLOBULIN INCREASED 3 0.0176
21 CHEST WALL TUMOUR 2 0.0167
22 ANAPLASTIC THYROID CANCER 2 0.0165
23 ANASTOMOTIC HAEMORRHAGE 3 0.0158
24 BODY SURFACE AREA INCREASED 2 0.0155
25 LEUKODERMA 3 0.0151
26 CRANIAL NERVE PALSIES MULTIPLE 2 0.0143
27 LARGE INTESTINAL ULCER 38 0.0140
28 ACUTE POLYNEUROPATHY 4 0.0140
29 CHORIORETINITIS 9 0.0140
30 RETINOPATHY 51 0.0137
31 XANTHOPSIA 5 0.0136
32 RETINAL OEDEMA 25 0.0131
33 CREATINE KINASE INCREASED 10 0.0130
34 DROPPED HEAD SYNDROME 5 0.0127
35 LENTIGO 6 0.0121
36 PACHYMENINGITIS 3 0.0115
37 HALO VISION 13 0.0115
38 RETROPERITONEAL LYMPHADENOPATHY 6 0.0114
39 NEOPLASM PROGRESSION 395 0.0113
40 LYMPHOCYTIC HYPOPHYSITIS 3 0.0109
41 ENTEROCOLITIS BACTERIAL 3 0.0109
42 AUTOIMMUNE COLITIS 7 0.0109
43 DEMYELINATING POLYNEUROPATHY 11 0.0107
44 RETINAL DETACHMENT 96 0.0104
45 SECOND PRIMARY MALIGNANCY 86 0.0103
46 GASTROINTESTINAL ANASTOMOTIC LEAK 4 0.0103
47 CHORIORETINOPATHY 14 0.0098
48 IMMUNE-MEDIATED HEPATITIS 20 0.0098
49 TUMOUR ASSOCIATED FEVER 4 0.0098
50 ADULT FAILURE TO THRIVE 2 0.0094
51 INTERTRIGO 5 0.0092
52 BLOOD CREATINE PHOSPHOKINASE DECREASED 3 0.0091
53 CYSTOID MACULAR OEDEMA 17 0.0090
54 MACULAR OEDEMA 50 0.0089
55 DERMATITIS ACNEIFORM 53 0.0087
56 LARGE INTESTINAL ULCER HAEMORRHAGE 3 0.0086
57 IMMUNE-MEDIATED NEPHRITIS 4 0.0085
58 SMALL INTESTINE ULCER 5 0.0077
59 ACROCHORDON 10 0.0075
60 RETINITIS 13 0.0075
61 DYSCHROMATOPSIA 6 0.0072
62 GLIOSIS 3 0.0070
63 RADIATION NECROSIS 4 0.0070
64 IMMUNE-MEDIATED HYPOPHYSITIS 3 0.0067
65 BRAIN OPERATION 15 0.0066
66 ANASTOMOTIC ULCER 3 0.0065
67 METAMORPHOPSIA 12 0.0065
68 PYOGENIC GRANULOMA 3 0.0064
69 PRIMARY BILIARY CHOLANGITIS 3 0.0064
70 PULPITIS DENTAL 6 0.0064
71 BRAIN STEM HAEMORRHAGE 6 0.0063
72 DEFECT CONDUCTION INTRAVENTRICULAR 2 0.0062
73 BLOOD LACTATE DEHYDROGENASE DECREASED 2 0.0060
74 KERATOACANTHOMA 4 0.0058
75 ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED 2 0.0058
76 CARBOHYDRATE ANTIGEN 19-9 INCREASED 3 0.0057
77 ILEAL STENOSIS 10 0.0056
78 CELL DEATH 11 0.0055
79 MELANOCYTIC NAEVUS 24 0.0055
80 IMMUNE-MEDIATED ENTEROCOLITIS 20 0.0054
81 UVEITIS 73 0.0054
82 BODY TINEA 3 0.0054
83 CHOROIDITIS 2 0.0053
84 MECHANICAL ILEUS 3 0.0053
85 HYPOPITUITARISM 9 0.0052
86 RETINAL VASCULAR DISORDER 3 0.0051
87 IRIDOCYCLITIS 16 0.0051
88 INTESTINAL ULCER 8 0.0050
89 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 4 0.0050
90 TUMOUR LYSIS SYNDROME 44 0.0050
91 HAEMOPERITONEUM 4 0.0050
92 TUMOUR EXCISION 4 0.0050
93 ILEAL ULCER 5 0.0049
94 AMYLASE INCREASED 18 0.0049
95 SUSPECTED OFF LABEL USE 22 0.0049
96 BLOOD BILIRUBIN DECREASED 3 0.0049
97 CUTANEOUS SARCOIDOSIS 2 0.0046
98 IMMUNE-MEDIATED HEPATIC DISORDER 9 0.0046
99 TUMOUR PAIN 6 0.0046
100 HEPATIC CYTOLYSIS 56 0.0044
101 CARDIAC DYSFUNCTION 16 0.0043
102 RETINAL DISORDER 11 0.0042
103 SKIN TEXTURE ABNORMAL 4 0.0042
104 VASOGENIC CEREBRAL OEDEMA 3 0.0042
105 PALMOPLANTAR KERATODERMA 3 0.0041
106 NEOPLASM RECURRENCE 14 0.0041
107 METASTASES TO CENTRAL NERVOUS SYSTEM 53 0.0041
108 LYMPHADENECTOMY 4 0.0041
109 BODY HEIGHT INCREASED 2 0.0041
110 HOSPICE CARE 40 0.0040
111 THYROIDITIS 12 0.0040
112 ENTEROCOLITIS 23 0.0040
113 PERIPHERAL SENSORIMOTOR NEUROPATHY 5 0.0040
114 HYPOPHYSITIS 8 0.0040
115 BLOOD CREATINE PHOSPHOKINASE INCREASED 113 0.0039
116 LIPASE INCREASED 30 0.0039
117 RETINAL TOXICITY 4 0.0039
118 SKIN NEOPLASM EXCISION 3 0.0038
119 COLITIS 142 0.0037
120 MALIGNANT MELANOMA 50 0.0037
121 PARONYCHIA 16 0.0036
122 PERIPHERAL MOTOR NEUROPATHY 5 0.0036
123 IMMUNE-MEDIATED HYPOTHYROIDISM 4 0.0035
124 SKIN TOXICITY 20 0.0035
125 ENANTHEMA 2 0.0035
126 THALAMUS HAEMORRHAGE 3 0.0034
127 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 3 0.0034
128 DERMATITIS EXFOLIATIVE GENERALISED 11 0.0032
129 ERYTHEMA NODOSUM 11 0.0031
130 METASTASES TO MENINGES 7 0.0031
131 LUNG OPACITY 8 0.0030
132 SKIN PAPILLOMA 12 0.0030
133 IMMUNE-MEDIATED DERMATITIS 3 0.0030
134 EJECTION FRACTION DECREASED 46 0.0030
135 FLUID IMBALANCE 2 0.0028
136 PRERENAL FAILURE 4 0.0028
137 SEBORRHOEIC KERATOSIS 4 0.0028
138 IMMUNE-MEDIATED LUNG DISEASE 5 0.0027
139 GASTROINTESTINAL ULCER 6 0.0027
140 ENTEROCOLITIS HAEMORRHAGIC 4 0.0027
141 LARGE INTESTINAL HAEMORRHAGE 6 0.0027
142 GASTROINTESTINAL WALL THICKENING 4 0.0027
143 CORTISOL DECREASED 3 0.0026
144 BRAIN NEOPLASM 24 0.0026
145 CALCULUS URINARY 4 0.0026
146 AORTIC THROMBOSIS 3 0.0026
147 ARTERIAL THROMBOSIS 5 0.0026
148 CARCINOEMBRYONIC ANTIGEN INCREASED 5 0.0026
149 RASH MACULO-PAPULAR 57 0.0026
150 VITILIGO 6 0.0026
151 EMBOLISM ARTERIAL 3 0.0025
152 COLON CANCER METASTATIC 4 0.0025
153 GUILLAIN-BARRE SYNDROME 12 0.0025
154 OTITIS EXTERNA 3 0.0025
155 TUMOUR HAEMORRHAGE 7 0.0025
156 EYE OEDEMA 6 0.0024
157 ORAL MUCOSA EROSION 3 0.0024
158 TROPONIN T INCREASED 3 0.0024
159 ENTERITIS INFECTIOUS 4 0.0023
160 HEPATITIS 60 0.0023
161 PHYSICAL DECONDITIONING 6 0.0023
162 SKIN HYPOPIGMENTATION 4 0.0023
163 VITREOUS FLOATERS 22 0.0022
164 HEPATIC FUNCTION ABNORMAL 83 0.0022
165 BLOOD LOSS ANAEMIA 5 0.0022
166 HYDROCEPHALUS 12 0.0022
167 SKIN DEPIGMENTATION 3 0.0022
168 HYPERKERATOSIS 12 0.0022
169 ABULIA 2 0.0022
170 LARGE INTESTINE PERFORATION 15 0.0022
171 TUNNEL VISION 4 0.0021
172 PRODUCT USE IN UNAPPROVED INDICATION 524 0.0021
173 COLORECTAL CANCER METASTATIC 5 0.0021
174 INTRA-ABDOMINAL HAEMORRHAGE 5 0.0021
175 DUODENAL ULCER HAEMORRHAGE 6 0.0021
176 NEPHRITIS 7 0.0021
177 LIVER FUNCTION TEST INCREASED 45 0.0021
178 PNEUMONITIS 57 0.0021
179 CANCER SURGERY 2 0.0021
180 GASTROINTESTINAL TOXICITY 10 0.0021
181 VISUAL FIELD DEFECT 15 0.0021
182 RENAL INFARCT 3 0.0021
183 GLOMERULONEPHRITIS 5 0.0020
184 NORMOCYTIC ANAEMIA 3 0.0020
185 DUODENAL PERFORATION 2 0.0020
186 MALIGNANT NEOPLASM PROGRESSION 208 0.0020
187 DEVICE RELATED THROMBOSIS 2 0.0020
188 SMALL INTESTINAL HAEMORRHAGE 4 0.0020
189 LIVER DISORDER 88 0.0020
190 ASTIGMATISM 3 0.0020
191 METASTASES TO PERITONEUM 5 0.0020
192 BLOOD LACTATE DEHYDROGENASE INCREASED 31 0.0020
193 CANCER PAIN 5 0.0020
194 CHOLANGITIS SCLEROSING 4 0.0019
195 HYPOALBUMINAEMIA 15 0.0019
196 GASTROINTESTINAL PERFORATION 8 0.0019
197 ATRIAL TACHYCARDIA 4 0.0019
198 GAMMA-GLUTAMYLTRANSFERASE INCREASED 42 0.0019
199 ENTEROCOCCAL BACTERAEMIA 2 0.0019
200 OPTIC NERVE DISORDER 3 0.0019
201 HYPERPHOSPHATAEMIA 4 0.0019
202 VITREOUS DETACHMENT 4 0.0018
203 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 43 0.0018
204 DUODENAL ULCER 13 0.0018
205 ACARODERMATITIS 2 0.0018
206 ADRENAL INSUFFICIENCY 22 0.0018
207 ANAL HAEMORRHAGE 5 0.0018
208 MENINGITIS ASEPTIC 8 0.0018
209 COLITIS ISCHAEMIC 12 0.0018
210 RENAL TUBULAR DISORDER 5 0.0018
211 DISEASE PROGRESSION 205 0.0017
212 AUTOIMMUNE HEPATITIS 12 0.0017
213 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 4 0.0017
214 PUSTULE 4 0.0017
215 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 3 0.0017
216 COLON OPERATION 2 0.0017
217 ATYPICAL PNEUMONIA 5 0.0017
218 BILE DUCT STENOSIS 2 0.0017
219 HYPERPYREXIA 7 0.0017
220 ESSENTIAL HYPERTENSION 3 0.0016
221 PHOTOSENSITIVITY REACTION 27 0.0016
222 CHOLANGITIS 10 0.0016
223 PYREXIA 556 0.0016
224 ASPARTATE AMINOTRANSFERASE INCREASED 85 0.0016
225 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 12 0.0016
226 VISION BLURRED 216 0.0016
227 EMBOLISM 13 0.0016
228 CHOLESTASIS 30 0.0016
229 CARDIAC VENTRICULAR THROMBOSIS 2 0.0015
230 BILIARY OBSTRUCTION 2 0.0015
231 ABDOMINAL OPERATION 2 0.0015
232 PERIPHERAL SENSORY NEUROPATHY 9 0.0015
233 ADRENOCORTICAL INSUFFICIENCY ACUTE 3 0.0015
234 ALANINE AMINOTRANSFERASE INCREASED 94 0.0015
235 ACQUIRED GENE MUTATION 2 0.0015
236 THERAPY CHANGE 15 0.0015
237 ENCEPHALITIS AUTOIMMUNE 2 0.0015
238 INTESTINAL PERFORATION 17 0.0015
239 VISUAL IMPAIRMENT 186 0.0015
240 LARGE INTESTINAL STENOSIS 3 0.0015
241 MENINGITIS 10 0.0015
242 HYPERLACTACIDAEMIA 4 0.0015
243 EYE DISORDER 49 0.0015
244 LOWER GASTROINTESTINAL HAEMORRHAGE 11 0.0015
245 SARCOIDOSIS 7 0.0015
246 DERMATITIS PSORIASIFORM 3 0.0015
247 MYOSITIS 13 0.0014
248 DIABETIC METABOLIC DECOMPENSATION 2 0.0014
249 CARDIOVERSION 2 0.0014
250 ECHOCARDIOGRAM ABNORMAL 2 0.0014
251 PHOTOPSIA 9 0.0014
252 POLYNEUROPATHY 17 0.0014
253 EAR SWELLING 3 0.0014
254 JAUNDICE CHOLESTATIC 5 0.0014
255 AUDITORY DISORDER 2 0.0014
256 FACIAL PARALYSIS 12 0.0014
257 ENTERITIS 9 0.0014
258 CEREBELLAR HAEMORRHAGE 2 0.0014
259 ERYTHEMA MULTIFORME 13 0.0014
260 RETINAL VEIN OCCLUSION 4 0.0014
261 COCCYDYNIA 2 0.0014
262 BRAIN OEDEMA 17 0.0013
263 CARDIOTOXICITY 12 0.0013
264 LEFT VENTRICULAR DYSFUNCTION 9 0.0013
265 BRAIN NEOPLASM MALIGNANT 6 0.0013
266 BLOOD CREATININE INCREASED 87 0.0013
267 SQUAMOUS CELL CARCINOMA OF SKIN 8 0.0013
268 IRITIS 4 0.0013
269 HAIR GROWTH ABNORMAL 9 0.0013
270 IRON DEFICIENCY ANAEMIA 12 0.0013
271 METASTASES TO LUNG 15 0.0013
272 NEUROLOGICAL DECOMPENSATION 3 0.0013
273 PIGMENTATION DISORDER 8 0.0013
274 ESCHERICHIA BACTERAEMIA 3 0.0013
275 MELAENA 28 0.0013
276 FOREIGN BODY IN THROAT 4 0.0013
277 URINARY TRACT OBSTRUCTION 3 0.0013
278 NON-CARDIAC CHEST PAIN 4 0.0013
279 HYPOTHYROIDISM 40 0.0013
280 RENAL IMPAIRMENT 105 0.0012
281 DISINHIBITION 2 0.0012
282 PANNICULITIS 3 0.0012
283 LIVER ABSCESS 4 0.0012
284 TASTE DISORDER 25 0.0012
285 HYPOMAGNESAEMIA 17 0.0012
286 HYPERURICAEMIA 5 0.0012
287 ACUTE KIDNEY INJURY 185 0.0012
288 ILEUS 15 0.0012
289 THYROID FUNCTION TEST ABNORMAL 5 0.0012
290 HEPATOCELLULAR INJURY 17 0.0012
291 URINARY TRACT INFECTION BACTERIAL 3 0.0012
292 DRUG ERUPTION 21 0.0012
293 DRUG-INDUCED LIVER INJURY 37 0.0012
294 HEPATOTOXICITY 26 0.0012
295 METASTATIC NEOPLASM 5 0.0012
296 ACTINIC KERATOSIS 3 0.0012
297 GRANULOMA 4 0.0012
298 BASAL CELL CARCINOMA 18 0.0012
299 DISSEMINATED INTRAVASCULAR COAGULATION 16 0.0011
300 FACIAL PARESIS 4 0.0011
301 CONJUNCTIVAL HYPERAEMIA 4 0.0011
302 OFF LABEL USE 976 0.0011
303 BLOOD THYROID STIMULATING HORMONE DECREASED 5 0.0011
304 PRODUCT PRESCRIBING ERROR 26 0.0011
305 BLINDNESS TRANSIENT 8 0.0011
306 MACULE 3 0.0011
307 LOCALISED OEDEMA 5 0.0011
308 SKIN HYPERTROPHY 3 0.0011
309 PEMPHIGOID 8 0.0011
310 COLITIS MICROSCOPIC 5 0.0011
311 RESPIRATORY SYMPTOM 3 0.0011
312 RENAL DISORDER 49 0.0011
313 HEART VALVE INCOMPETENCE 3 0.0010
314 C-REACTIVE PROTEIN INCREASED 38 0.0010
315 ADRENAL DISORDER 2 0.0010
316 HYPERTHYROIDISM 15 0.0010
317 RASH VESICULAR 5 0.0010
318 ABDOMINAL WALL HAEMATOMA 2 0.0010
319 METASTASES TO LIVER 18 0.0010
320 RENAL TUBULAR NECROSIS 10 0.0010
321 CHILLS 119 0.0010
322 LYMPHOEDEMA 7 0.0010
323 ENCEPHALITIS 7 0.0010
324 BACTERAEMIA 12 0.0010
325 ORGANISING PNEUMONIA 5 0.0010
326 BLOOD ALBUMIN DECREASED 8 0.0010
327 COLON CANCER 15 0.0010
328 HYPERTRANSAMINASAEMIA 7 0.0010
329 CEREBRAL HAEMORRHAGE 36 0.0010
330 GASTRIC ULCER 19 0.0010
331 HEPATITIS CHOLESTATIC 6 0.0010
332 PRODUCT DOSE OMISSION 65 0.0010
333 INTERSTITIAL LUNG DISEASE 48 0.0010
334 TRANSAMINASES INCREASED 22 0.0010
335 DECREASED APPETITE 229 0.0010
336 RHABDOMYOLYSIS 41 0.0010
337 ESCHERICHIA INFECTION 8 0.0010
338 DEATH 836 0.0010
339 HEPATIC ENZYME INCREASED 66 0.0010
340 MULTIPLE-DRUG RESISTANCE 3 0.0010
341 DIARRHOEA HAEMORRHAGIC 9 0.0010
342 PHOTOPHOBIA 18 0.0010
343 BLOOD SODIUM DECREASED 18 0.0010
344 POLYARTHRITIS 5 0.0009
345 INTESTINAL STENOSIS 4 0.0009
346 CEREBRAL DISORDER 7 0.0009
347 ELECTROCARDIOGRAM QT PROLONGED 34 0.0009
348 RASH 407 0.0009
349 BLOOD IRON DECREASED 11 0.0009
350 HEPATIC LESION 4 0.0009
351 NAUSEA 731 0.0009
352 HEPATITIS ACUTE 6 0.0009
353 BONE CANCER 4 0.0009
354 NEAR DEATH EXPERIENCE 3 0.0009
355 CLOSTRIDIUM TEST POSITIVE 2 0.0009
356 LYMPHOCYTE COUNT DECREASED 16 0.0009
357 ELECTROCARDIOGRAM T WAVE INVERSION 2 0.0009
358 GASTRIC ULCER HAEMORRHAGE 5 0.0009
359 DIARRHOEA 579 0.0009
360 BACTERIAL TEST POSITIVE 2 0.0009
361 GLOMERULAR FILTRATION RATE DECREASED 11 0.0009
362 SMALL INTESTINAL OBSTRUCTION 11 0.0009
363 VOMITING 420 0.0009
364 METASTASES TO SPINE 3 0.0009
365 IRON DEFICIENCY 4 0.0009
366 PRODUCT USE COMPLAINT 14 0.0009
367 PERIORBITAL SWELLING 5 0.0009
368 COMPUTERISED TOMOGRAM ABNORMAL 2 0.0009
369 NEPHROTIC SYNDROME 6 0.0009
370 CENTRAL NERVOUS SYSTEM LESION 12 0.0009
371 SKIN DISORDER 29 0.0009
372 FLAT AFFECT 2 0.0009
373 SKIN TIGHTNESS 4 0.0008
374 MACULOPATHY 3 0.0008
375 VISUAL ACUITY REDUCED 28 0.0008
376 DYSPHAGIA 80 0.0008
377 CARDIAC TAMPONADE 4 0.0008
378 METASTASIS 6 0.0008
379 SEIZURE 97 0.0008
380 TUMOUR MARKER INCREASED 4 0.0008
381 THERAPY PARTIAL RESPONDER 13 0.0008
382 THYROID CANCER 10 0.0008
383 DIABETES INSIPIDUS 2 0.0008
384 HEMIPARESIS 14 0.0008
385 ANAEMIA 155 0.0008
386 MYALGIA 138 0.0008
387 BLINDNESS 33 0.0008
388 DEHYDRATION 108 0.0008
389 HYPERNATRAEMIA 4 0.0008
390 CONSTIPATION 175 0.0008
391 HEPATIC ENZYME ABNORMAL 4 0.0008
392 OCULAR DISCOMFORT 9 0.0008
393 TUBULOINTERSTITIAL NEPHRITIS 15 0.0008
394 METASTASES TO BONE 13 0.0008
395 RECTAL HAEMORRHAGE 34 0.0008
396 PATHOLOGICAL FRACTURE 4 0.0008
397 FATIGUE 611 0.0008
398 ANGLE CLOSURE GLAUCOMA 2 0.0008
399 NEOPLASM 9 0.0008
400 ABDOMINAL INFECTION 2 0.0008
401 GASTROINTESTINAL INFECTION 7 0.0008
402 ENDOCARDITIS 4 0.0008
403 INTESTINAL OBSTRUCTION 29 0.0008
404 PARTIAL SEIZURES 4 0.0008
405 UROSEPSIS 7 0.0008
406 ABDOMINAL MASS 2 0.0007
407 PRODUCT SIZE ISSUE 4 0.0007
408 HYPOACUSIS 32 0.0007
409 METASTASES TO LYMPH NODES 5 0.0007
410 FEEDING DISORDER 15 0.0007
411 RECURRENT CANCER 3 0.0007
412 LEG AMPUTATION 3 0.0007
413 HYPONATRAEMIA 41 0.0007
414 GASTROINTESTINAL PAIN 8 0.0007
415 GENERALISED OEDEMA 9 0.0007
416 SPINAL STENOSIS 3 0.0007
417 RED CELL DISTRIBUTION WIDTH INCREASED 3 0.0007
418 COLITIS ULCERATIVE 32 0.0007
419 NEPHROPATHY TOXIC 8 0.0007
420 PANCREATITIS ACUTE 16 0.0007
421 ILLNESS 73 0.0007
422 MUSCLE FATIGUE 3 0.0007
423 CEREBRAL THROMBOSIS 2 0.0007
424 BRAIN FOG 11 0.0007
425 INTERNAL HAEMORRHAGE 8 0.0007
426 PANCREATITIS 37 0.0007
427 THERAPY INTERRUPTED 50 0.0007
428 MYOCARDITIS 8 0.0007
429 CYTOKINE RELEASE SYNDROME 14 0.0007
430 BLOOD MAGNESIUM DECREASED 6 0.0007
431 MYOPATHY 6 0.0007
432 HYPOKALAEMIA 32 0.0007
433 STRESS CARDIOMYOPATHY 4 0.0007
434 BLOOD CREATINE INCREASED 3 0.0007
435 CARDIOMYOPATHY 10 0.0007
436 HAEMATOCHEZIA 37 0.0007
437 HAEMORRHAGE INTRACRANIAL 10 0.0007
438 URINARY TRACT DISORDER 3 0.0007
439 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
440 EMERGENCY CARE 2 0.0007
441 EMBOLISM VENOUS 2 0.0007
442 EPILEPSY 20 0.0007
443 DYSAESTHESIA 2 0.0007
444 FACE OEDEMA 11 0.0007
445 NEUROPATHY PERIPHERAL 62 0.0007
446 PRESCRIBED UNDERDOSE 13 0.0007
447 PERICARDIAL EFFUSION 15 0.0006
448 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
449 RENAL FUNCTION TEST ABNORMAL 3 0.0006
450 GASTRITIS 17 0.0006
451 BLOOD ALKALINE PHOSPHATASE INCREASED 16 0.0006
452 BLOOD TEST ABNORMAL 9 0.0006
453 SQUAMOUS CELL CARCINOMA 6 0.0006
454 APHASIA 19 0.0006
455 EYE INFLAMMATION 6 0.0006
456 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
457 HYPERCHOLESTEROLAEMIA 6 0.0006
458 SKIN LESION 17 0.0006
459 AUTOIMMUNE DISORDER 6 0.0006
460 HAEMORRHOIDAL HAEMORRHAGE 3 0.0006
461 SHOCK HAEMORRHAGIC 5 0.0006
462 ABDOMINAL PAIN 142 0.0006
463 RASH PRURITIC 33 0.0006
464 DEAFNESS NEUROSENSORY 2 0.0006
465 THERAPY CESSATION 31 0.0006
466 ELECTROLYTE IMBALANCE 7 0.0006
467 CARDIAC FAILURE ACUTE 4 0.0006
468 FLUID INTAKE REDUCED 3 0.0006
469 SKIN MASS 4 0.0006
470 ERYSIPELAS 3 0.0006
471 CEREBRAL HAEMATOMA 2 0.0006
472 ULCER HAEMORRHAGE 4 0.0006
473 ATAXIA 7 0.0006
474 GENERAL PHYSICAL CONDITION ABNORMAL 4 0.0006
475 B-CELL LYMPHOMA 2 0.0006
476 CHOLECYSTITIS 7 0.0006
477 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 15 0.0006
478 ASCITES 17 0.0006
479 BLOOD CREATININE ABNORMAL 2 0.0006
480 EXTRASYSTOLES 4 0.0006
481 PULMONARY TOXICITY 4 0.0006
482 GENERAL PHYSICAL HEALTH DETERIORATION 65 0.0006
483 RETINAL HAEMORRHAGE 4 0.0006
484 INTENTIONAL DOSE OMISSION 16 0.0006
485 FOOD POISONING 3 0.0006
486 DRUG INTOLERANCE 54 0.0006
487 VERTIGO 34 0.0006
488 RENAL FAILURE 74 0.0006
489 HEAVY MENSTRUAL BLEEDING 5 0.0006
490 OROPHARYNGEAL DISCOMFORT 5 0.0006
491 ARTHRALGIA 230 0.0006
492 TONGUE DISORDER 4 0.0006
493 LEUKOCYTOSIS 10 0.0006
494 SKIN LACERATION 6 0.0006
495 HYPOPHAGIA 14 0.0005
496 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 16 0.0005
497 BLOOD THYROID STIMULATING HORMONE INCREASED 5 0.0005
498 DENTAL CARIES 6 0.0005
499 LABORATORY TEST ABNORMAL 16 0.0005
500 HYPERKALAEMIA 19 0.0005
501 HYPOPHOSPHATAEMIA 4 0.0005
502 SKIN INFECTION 6 0.0005
503 OEDEMA 29 0.0005
504 EYE INFECTION 6 0.0005
505 MALAISE 233 0.0005
506 TENDON PAIN 4 0.0005
507 TOXIC EPIDERMAL NECROLYSIS 8 0.0005
508 DERMATITIS 11 0.0005
509 NEUROLOGICAL SYMPTOM 3 0.0005
510 HAIR TEXTURE ABNORMAL 7 0.0005
511 MOUTH SWELLING 3 0.0005
512 HYPOTENSION 104 0.0005
513 SPEECH DISORDER 27 0.0005
514 CARDIAC FAILURE 41 0.0005
515 URINE ODOUR ABNORMAL 3 0.0005
516 PLEURAL EFFUSION 31 0.0005
517 ALTERED STATE OF CONSCIOUSNESS 11 0.0005
518 PLEURISY 3 0.0005
519 RASH ERYTHEMATOUS 24 0.0005
520 URINARY TRACT INFECTION 85 0.0005
521 PNEUMOCYSTIS JIROVECII PNEUMONIA 5 0.0005
522 HEPATIC FAILURE 15 0.0005
523 MUCOSAL INFLAMMATION 13 0.0005
524 TOXIC SKIN ERUPTION 5 0.0005
525 PRODUCT USE ISSUE 93 0.0005
526 MULTIPLE ORGAN DYSFUNCTION SYNDROME 14 0.0005
527 MUSCULAR WEAKNESS 56 0.0005
528 BLOOD POTASSIUM INCREASED 8 0.0005
529 MOTOR DYSFUNCTION 5 0.0005
530 ENCEPHALOPATHY 12 0.0005
531 SEPSIS 54 0.0005
532 BLOOD BILIRUBIN INCREASED 13 0.0005
533 LYMPHADENOPATHY 17 0.0005
534 SKIN DISCOLOURATION 22 0.0005
535 UPPER GASTROINTESTINAL HAEMORRHAGE 8 0.0005
536 SKIN PLAQUE 4 0.0005
537 CARDIAC FAILURE CHRONIC 2 0.0005
538 ASTHENIA 176 0.0005
539 PERIPHERAL SWELLING 72 0.0005
540 ABDOMINAL PAIN UPPER 96 0.0005
541 UNDERDOSE 34 0.0005
542 ABDOMINAL DISCOMFORT 78 0.0005
543 INCOHERENT 3 0.0005
544 PULMONARY EMBOLISM 44 0.0005
545 PYELONEPHRITIS 4 0.0005
546 CHAPPED LIPS 2 0.0005
547 SKIN FISSURES 9 0.0005
548 REFUSAL OF TREATMENT BY PATIENT 3 0.0005
549 COLD SWEAT 8 0.0005
550 APPETITE DISORDER 3 0.0005
551 NERVE INJURY 5 0.0004
552 RASH PAPULAR 10 0.0004
553 PAIN OF SKIN 12 0.0004
554 GASTROINTESTINAL HAEMORRHAGE 37 0.0004
555 DRY SKIN 59 0.0004
556 PNEUMOTHORAX 7 0.0004
557 OPTIC NEURITIS 4 0.0004
558 ULCER 7 0.0004
559 CONFUSIONAL STATE 71 0.0004
560 ALOPECIA 86 0.0004
561 STOMATITIS 26 0.0004
562 HAEMOGLOBIN DECREASED 44 0.0004
563 PRODUCT DOSE OMISSION IN ERROR 12 0.0004
564 PARALYSIS 6 0.0004
565 SKIN CANCER 9 0.0004
566 ACUTE RESPIRATORY FAILURE 8 0.0004
567 DERMATITIS BULLOUS 3 0.0004
568 ENTEROCOCCAL INFECTION 2 0.0004
569 PRODUCT PRESCRIBING ISSUE 9 0.0004
570 LIVER FUNCTION TEST ABNORMAL 12 0.0004
571 HYPERGLYCAEMIA 15 0.0004
572 UTERINE LEIOMYOMA 3 0.0004
573 HAEMORRHOIDS 8 0.0004
574 HAEMATURIA 14 0.0004
575 CYTOPENIA 5 0.0004
576 SENSITIVE SKIN 3 0.0004
577 HYPERCALCAEMIA 5 0.0004
578 HAIR COLOUR CHANGES 5 0.0004
579 ANEURYSM 2 0.0004
580 HYDRONEPHROSIS 3 0.0004
581 GENERAL SYMPTOM 3 0.0004
582 EOSINOPHILIA 7 0.0004
583 ACNE 30 0.0004
584 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
585 TROPONIN INCREASED 3 0.0004
586 HYPERTHERMIA 3 0.0004
587 SUBARACHNOID HAEMORRHAGE 4 0.0004
588 SLUGGISHNESS 4 0.0004
589 SHOCK 9 0.0004
590 GASTROINTESTINAL DISORDER 35 0.0004
591 ADVERSE EVENT 36 0.0004
592 ERECTILE DYSFUNCTION 10 0.0004
593 ATRIOVENTRICULAR BLOCK 3 0.0004
594 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
595 HYPERBILIRUBINAEMIA 4 0.0004
596 PLATELET COUNT DECREASED 41 0.0004
597 TENDERNESS 4 0.0004
598 HYPERSOMNIA 11 0.0004
599 ABDOMINAL DISTENSION 40 0.0004
600 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
601 DRY EYE 19 0.0004
602 ORAL CANDIDIASIS 5 0.0004
603 INCONTINENCE 4 0.0004
604 OEDEMA PERIPHERAL 46 0.0004
605 RENAL PAIN 4 0.0004
606 CONJUNCTIVITIS 7 0.0004
607 AGRANULOCYTOSIS 7 0.0004
608 EATING DISORDER 8 0.0004
609 MYASTHENIA GRAVIS 3 0.0004
610 MUSCLE DISORDER 3 0.0004
611 PRESYNCOPE 9 0.0004
612 NEURALGIA 9 0.0004
613 HYPOCALCAEMIA 7 0.0004
614 FRACTURE 7 0.0004
615 CHEILITIS 2 0.0004
616 CATARACT 22 0.0004
617 ERYTHEMA OF EYELID 2 0.0004
618 FAECES DISCOLOURED 8 0.0004
619 POST PROCEDURAL INFECTION 3 0.0004
620 PRURITUS 141 0.0004
621 HYPERAESTHESIA 3 0.0004
622 POST PROCEDURAL COMPLICATION 7 0.0004
623 DEAFNESS UNILATERAL 2 0.0004
624 SPINAL COMPRESSION FRACTURE 3 0.0004
625 EOSINOPHIL COUNT INCREASED 3 0.0004
626 FEELING COLD 10 0.0004
627 OCULAR HYPERAEMIA 17 0.0004
628 MALNUTRITION 4 0.0004
629 ORAL PAIN 8 0.0004
630 ADVERSE DRUG REACTION 32 0.0004
631 BLINDNESS UNILATERAL 5 0.0004
632 LYMPHOPENIA 5 0.0004
633 CARDIAC DISORDER 33 0.0004
634 GASTRIC HAEMORRHAGE 4 0.0003
635 RASH GENERALISED 9 0.0003
636 MUSCLE STRAIN 3 0.0003
637 DIPLOPIA 9 0.0003
638 INFECTION 50 0.0003
639 HYPERTENSION 73 0.0003
640 ORTHOSTATIC HYPOTENSION 6 0.0003
641 EYELID OEDEMA 4 0.0003
642 RASH MACULAR 12 0.0003
643 GROIN PAIN 3 0.0003
644 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
645 HYPOXIA 12 0.0003
646 WEIGHT DECREASED 95 0.0003
647 IMMUNOSUPPRESSION 3 0.0003
648 BRADYKINESIA 2 0.0003
649 MUSCLE SPASMS 62 0.0003
650 CELLULITIS 17 0.0003
651 CATARACT OPERATION 2 0.0003
652 MACULAR DEGENERATION 4 0.0003
653 BLOOD POTASSIUM DECREASED 10 0.0003
654 LIP SWELLING 11 0.0003
655 GAIT INABILITY 11 0.0003
656 DISORIENTATION 13 0.0003
657 LUNG DISORDER 16 0.0003
658 OVARIAN CANCER 3 0.0003
659 DEVICE RELATED INFECTION 5 0.0003
660 THYROID DISORDER 5 0.0003
661 MENTAL STATUS CHANGES 9 0.0003
662 BALANCE DISORDER 28 0.0003
663 DEEP VEIN THROMBOSIS 21 0.0003
664 MUSCULOSKELETAL CHEST PAIN 5 0.0003
665 CYST 4 0.0003
666 DEMENTIA 9 0.0003
667 APPENDICITIS 3 0.0003
668 PNEUMONIA ASPIRATION 8 0.0003
669 INFUSION RELATED REACTION 21 0.0003
670 MEMORY IMPAIRMENT 43 0.0003
671 THERAPEUTIC RESPONSE UNEXPECTED 14 0.0003
672 DRUG RESISTANCE 8 0.0003
673 THROMBOSIS 25 0.0003
674 SINUS BRADYCARDIA 3 0.0003
675 CHROMATURIA 7 0.0003
676 NODULE 4 0.0003
677 JOINT STIFFNESS 8 0.0003
678 COVID-19 53 0.0003
679 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
680 ADVERSE REACTION 4 0.0003
681 FEBRILE NEUTROPENIA 20 0.0003
682 FLATULENCE 17 0.0003
683 EYE HAEMORRHAGE 4 0.0003
684 URINARY RETENTION 10 0.0003
685 SEPTIC SHOCK 13 0.0003
686 ATRIAL FIBRILLATION 29 0.0003
687 EYE SWELLING 11 0.0003
688 CIRCULATORY COLLAPSE 5 0.0003
689 DYSPNOEA EXERTIONAL 11 0.0003
690 HELICOBACTER INFECTION 3 0.0003
691 INFLAMMATION 15 0.0003
692 DIVERTICULITIS 8 0.0003
693 BACK PAIN 67 0.0003
694 HAEMORRHAGE 30 0.0003
695 BLOOD PRESSURE DECREASED 19 0.0003
696 LIVER INJURY 7 0.0003
697 POOR QUALITY PRODUCT ADMINISTERED 3 0.0003
698 HALLUCINATION, VISUAL 6 0.0003
699 SUDDEN DEATH 3 0.0003
700 DIALYSIS 4 0.0003
701 SINUS TACHYCARDIA 4 0.0003
702 RETCHING 6 0.0003
703 LOSS OF CONSCIOUSNESS 36 0.0003
704 SYNCOPE 28 0.0003
705 SUBDURAL HAEMATOMA 4 0.0003
706 NIGHT SWEATS 9 0.0003
707 SWELLING FACE 18 0.0003
708 MENTAL DISORDER 12 0.0003
709 PRODUCT DISPENSING ERROR 6 0.0003
710 PULMONARY THROMBOSIS 3 0.0003
711 FAECES SOFT 2 0.0003
712 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
713 OESOPHAGITIS 3 0.0003
714 GASTROENTERITIS 4 0.0003
715 BONE PAIN 16 0.0003
716 VIRAL INFECTION 9 0.0003
717 INFLUENZA LIKE ILLNESS 22 0.0003
718 BLOOD CALCIUM DECREASED 3 0.0003
719 MITRAL VALVE INCOMPETENCE 3 0.0003
720 BLOOD COUNT ABNORMAL 4 0.0003
721 POLLAKIURIA 11 0.0003
722 SCAB 3 0.0003
723 PROTEINURIA 5 0.0003
724 MUSCULOSKELETAL DISORDER 5 0.0003
725 BOWEL MOVEMENT IRREGULARITY 2 0.0003
726 HOSPITALISATION 40 0.0003
727 THROMBOCYTOPENIA 29 0.0003
728 FOOD ALLERGY 2 0.0003
729 ERUCTATION 5 0.0003
730 PRESCRIBED OVERDOSE 5 0.0003
731 HEART RATE DECREASED 9 0.0003
732 NEOPLASM MALIGNANT 17 0.0003
733 COVID-19 PNEUMONIA 3 0.0003
734 PAIN 156 0.0003
735 HALLUCINATION, AUDITORY 4 0.0003
736 CYSTITIS 8 0.0003
737 PAIN IN EXTREMITY 74 0.0003
738 ATRIAL FLUTTER 2 0.0003
739 WRIST FRACTURE 3 0.0003
740 BLISTER 14 0.0002
741 MENTAL IMPAIRMENT 6 0.0002
742 HYPOAESTHESIA 37 0.0002
743 DRY MOUTH 20 0.0002
744 PULMONARY OEDEMA 11 0.0002
745 DYSPEPSIA 24 0.0002
746 SPINAL OPERATION 3 0.0002
747 DYSPNOEA 137 0.0002
748 TOOTH EXTRACTION 3 0.0002
749 PNEUMONIA 78 0.0002
750 AGEUSIA 6 0.0002
751 DYSSTASIA 7 0.0002
752 DYSPHONIA 14 0.0002
753 BLOOD UREA INCREASED 4 0.0002
754 TYPE 2 DIABETES MELLITUS 8 0.0002
755 HEADACHE 148 0.0002
756 FLUID RETENTION 12 0.0002
757 RESPIRATORY DISORDER 7 0.0002
758 URTICARIA 39 0.0002
759 POOR QUALITY SLEEP 5 0.0002
760 JOINT SWELLING 28 0.0002
761 DELIRIUM 8 0.0002
762 PLATELET COUNT INCREASED 3 0.0002
763 DEAFNESS 6 0.0002
764 ECZEMA 12 0.0002
765 BLOOD CALCIUM INCREASED 2 0.0002
766 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
767 DYSMENORRHOEA 3 0.0002
768 DIZZINESS 112 0.0002
769 ISCHAEMIC STROKE 4 0.0002
770 GALLBLADDER DISORDER 4 0.0002
771 SOMNOLENCE 45 0.0002
772 HYPERSENSITIVITY 41 0.0002
773 RESTLESS LEGS SYNDROME 4 0.0002
774 GINGIVAL BLEEDING 3 0.0002
775 ACUTE HEPATIC FAILURE 3 0.0002
776 BONE DISORDER 4 0.0002
777 LUNG NEOPLASM MALIGNANT 9 0.0002
778 ANAPHYLACTIC REACTION 12 0.0002
779 MUSCLE TWITCHING 5 0.0002
780 MASS 3 0.0002
781 CARPAL TUNNEL SYNDROME 3 0.0002
782 COGNITIVE DISORDER 10 0.0002
783 FLANK PAIN 2 0.0002
784 SKIN REACTION 3 0.0002
785 BLOOD URINE PRESENT 4 0.0002
786 RED BLOOD CELL COUNT DECREASED 6 0.0002
787 PRODUCTIVE COUGH 10 0.0002
788 INCREASED APPETITE 4 0.0002
789 CARDIOGENIC SHOCK 3 0.0002
790 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
791 GLAUCOMA 4 0.0002
792 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
793 DIZZINESS POSTURAL 2 0.0002
794 RESPIRATORY FAILURE 15 0.0002
795 INTENTIONAL PRODUCT MISUSE 18 0.0002
796 CEREBRAL INFARCTION 5 0.0002
797 GASTRIC DISORDER 7 0.0002
798 ACUTE MYOCARDIAL INFARCTION 6 0.0002
799 BODY TEMPERATURE DECREASED 2 0.0002
800 URINARY INCONTINENCE 6 0.0002
801 BLADDER DISORDER 2 0.0002
802 BLOOD PRESSURE ABNORMAL 4 0.0002
803 AMNESIA 13 0.0002
804 SPINAL FRACTURE 4 0.0002
805 ERYTHEMA 41 0.0002
806 HALLUCINATION 15 0.0002
807 HYPOAESTHESIA ORAL 3 0.0002
808 GASTROOESOPHAGEAL REFLUX DISEASE 16 0.0002
809 LACRIMATION INCREASED 6 0.0002
810 FALL 66 0.0002
811 CONDITION AGGRAVATED 60 0.0002
812 PANCYTOPENIA 11 0.0002
813 COUGH 55 0.0002
814 BODY TEMPERATURE INCREASED 4 0.0002
815 EYE PAIN 11 0.0002
816 CEREBROVASCULAR ACCIDENT 33 0.0002
817 OROPHARYNGEAL PAIN 18 0.0002
818 PULMONARY HYPERTENSION 4 0.0002
819 HERPES ZOSTER 11 0.0002
820 LETHARGY 11 0.0002
821 FOLLICULITIS 2 0.0002
822 DYSURIA 7 0.0002
823 ARRHYTHMIA 9 0.0002
824 SKIN EXFOLIATION 16 0.0002
825 DISEASE RECURRENCE 9 0.0002
826 FULL BLOOD COUNT ABNORMAL 2 0.0002
827 DYSGEUSIA 14 0.0002
828 INFLUENZA 21 0.0002
829 SCIATICA 3 0.0002
830 METABOLIC ACIDOSIS 6 0.0002
831 BLOOD GLUCOSE DECREASED 9 0.0002
832 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 9 0.0002
833 EPISTAXIS 14 0.0002
834 SENSORY DISTURBANCE 3 0.0002
835 IRRITABLE BOWEL SYNDROME 4 0.0002
836 MUSCLE TIGHTNESS 3 0.0002
837 PRURITUS GENERALISED 4 0.0002
838 BACK INJURY 2 0.0002
839 IMPAIRED HEALING 6 0.0002
840 VENTRICULAR TACHYCARDIA 3 0.0002
841 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
842 MOBILITY DECREASED 13 0.0002
843 TACHYCARDIA 16 0.0002
844 LEUKOPENIA 9 0.0002
845 HAEMOPTYSIS 5 0.0002
846 ARTHRITIS 14 0.0002
847 PARAESTHESIA 28 0.0002
848 CANDIDA INFECTION 3 0.0002
849 DRUG INTERACTION 28 0.0002
850 AMENORRHOEA 3 0.0002
851 SWELLING 16 0.0002
852 PRODUCT DOSE OMISSION ISSUE 50 0.0002
853 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
854 CHEST PAIN 31 0.0002
855 DIABETIC KETOACIDOSIS 4 0.0002
856 GASTROENTERITIS VIRAL 3 0.0002
857 HYPERHIDROSIS 21 0.0002
858 BLOOD GLUCOSE ABNORMAL 3 0.0002
859 HEART RATE INCREASED 16 0.0002
860 NERVOUS SYSTEM DISORDER 5 0.0002
861 UNEVALUABLE EVENT 12 0.0002
862 ABDOMINAL PAIN LOWER 4 0.0002
863 CARDIOVASCULAR DISORDER 4 0.0002
864 GAIT DISTURBANCE 30 0.0002
865 SLEEP DISORDER 11 0.0002
866 CONTUSION 15 0.0002
867 MOVEMENT DISORDER 5 0.0002
868 EAR PAIN 3 0.0002
869 TOXICITY TO VARIOUS AGENTS 26 0.0002
870 INSOMNIA 41 0.0002
871 CHOKING 3 0.0002
872 KIDNEY INFECTION 3 0.0002
873 MENORRHAGIA 3 0.0002
874 STAPHYLOCOCCAL INFECTION 5 0.0002
875 DEPRESSED MOOD 8 0.0002
876 BLOOD CHOLESTEROL INCREASED 7 0.0002
877 CARDIAC FAILURE CONGESTIVE 12 0.0001
878 PRODUCT ADMINISTRATION ERROR 3 0.0001
879 DISTURBANCE IN ATTENTION 8 0.0001
880 THROAT TIGHTNESS 4 0.0001
881 LIMB INJURY 4 0.0001
882 PALLOR 4 0.0001
883 HYPOGLYCAEMIA 7 0.0001
884 DIABETES MELLITUS 11 0.0001
885 BLOOD PRESSURE INCREASED 22 0.0001
886 APHONIA 2 0.0001
887 WOUND 4 0.0001
888 WEIGHT INCREASED 32 0.0001
889 BURNING SENSATION 10 0.0001
890 FEELING ABNORMAL 34 0.0001
891 OSTEOARTHRITIS 6 0.0001
892 PAIN IN JAW 4 0.0001
893 JOINT INJURY 3 0.0001
894 NEUTROPENIA 19 0.0001
895 EYE IRRITATION 8 0.0001
896 ANOSMIA 2 0.0001
897 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
898 ACCIDENTAL OVERDOSE 5 0.0001
899 SURGERY 8 0.0001
900 RENAL INJURY 4 0.0001
901 NERVOUSNESS 7 0.0001
902 HEART RATE IRREGULAR 3 0.0001
903 TREMOR 22 0.0001
904 ILL-DEFINED DISORDER 8 0.0001
905 NEPHROLITHIASIS 6 0.0001
906 TINNITUS 6 0.0001
907 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
908 LIMB DISCOMFORT 4 0.0001
909 PALPITATIONS 15 0.0001
910 BLOOD GLUCOSE INCREASED 24 0.0001
911 HEAD INJURY 4 0.0001
912 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
913 NECK PAIN 7 0.0001
914 LOCALISED INFECTION 3 0.0001
915 DYSKINESIA 5 0.0001
916 CHOLELITHIASIS 4 0.0001
917 CYTOMEGALOVIRUS INFECTION 2 0.0001
918 COAGULOPATHY 2 0.0001
919 FUNGAL INFECTION 4 0.0001
920 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
921 HAEMATEMESIS 3 0.0001
922 ANAPHYLACTIC SHOCK 3 0.0001
923 MIGRAINE 11 0.0001
924 MYOCARDIAL INFARCTION 20 0.0001
925 MUSCULOSKELETAL PAIN 6 0.0001
926 ANGIOEDEMA 5 0.0001
927 SKIN BURNING SENSATION 8 0.0001
928 RESTLESSNESS 4 0.0001
929 CARDIAC ARREST 9 0.0001
930 PROCEDURAL PAIN 3 0.0001
931 ARTHROPATHY 6 0.0001
932 SINUSITIS 11 0.0001
933 DYSARTHRIA 4 0.0001
934 HOT FLUSH 8 0.0001
935 CHRONIC KIDNEY DISEASE 8 0.0001
936 ANGINA PECTORIS 3 0.0001
937 DYSTONIA 2 0.0001
938 EXTRA DOSE ADMINISTERED 4 0.0001
939 PSORIATIC ARTHROPATHY 4 0.0001
940 DISCOMFORT 6 0.0001
941 NEUTROPHIL COUNT DECREASED 4 0.0001
942 CHEST DISCOMFORT 10 0.0001
943 NASOPHARYNGITIS 18 0.0001
944 RHEUMATOID ARTHRITIS 11 0.0001
945 FEMUR FRACTURE 3 0.0001
946 SWOLLEN TONGUE 3 0.0001
947 HIP FRACTURE 3 0.0001
948 WHITE BLOOD CELL COUNT DECREASED 10 0.0001
949 TREATMENT NONCOMPLIANCE 5 0.0001
950 OSTEONECROSIS 3 0.0001
951 EXPIRED PRODUCT ADMINISTERED 3 0.0001
952 OXYGEN SATURATION DECREASED 5 0.0001
953 FLUSHING 9 0.0001
954 SKIN IRRITATION 4 0.0001
955 TREATMENT FAILURE 7 0.0001
956 MYELOSUPPRESSION 3 0.0001
957 IRRITABILITY 5 0.0001
958 FIBROMYALGIA 2 0.0001
959 FEELING HOT 5 0.0001
960 DEPRESSION 18 0.0001
961 BRADYCARDIA 4 0.0001
962 FREQUENT BOWEL MOVEMENTS 2 0.0001
963 DRUG INEFFECTIVE 97 0.0001
964 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
965 ABNORMAL DREAMS 2 0.0001
966 ANXIETY 20 0.0001
967 VAGINAL HAEMORRHAGE 3 0.0001
968 PSORIASIS 9 0.0001
969 INTENTIONAL PRODUCT USE ISSUE 6 0.0001
970 MUSCULOSKELETAL STIFFNESS 6 0.0001
971 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 13 0.0001
972 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 11 0.0001
973 EYE PRURITUS 2 0.0001
974 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
975 CRYING 2 0.0001
976 BRONCHITIS 4 0.0001
977 MEDICATION ERROR 3 0.0001
978 NASAL CONGESTION 3 0.0001
979 OVERDOSE 11 0.0001
980 WHEEZING 3 0.0001
981 THERAPEUTIC RESPONSE DECREASED 3 0.0000
982 CARDIO-RESPIRATORY ARREST 2 0.0000
983 RHINORRHOEA 3 0.0000
984 ASTHMA 5 0.0000
985 NO ADVERSE EVENT 8 0.0000
986 SUICIDAL IDEATION 4 0.0000
987 COMA 2 0.0000
988 PRODUCT STORAGE ERROR 3 0.0000
989 EXPOSURE DURING PREGNANCY 2 0.0000
990 AGITATION 2 0.0000
991 INCORRECT DOSE ADMINISTERED 4 0.0000